Skip to content
Q3 2019 GoPro Inc Earnings Call...
ChemoCentryx (CCXI) is on everyone’s radar Tuesday, with shares flying higher by more than 350% at one point. The ride was instigated by the positive results from the phase 3 ADVOCATE study of Avacopan, an oral 5a receptor inhibitor, used for the treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (ANCA-associated vasculitis).ANCA Associated Vasculitis (AAV) is a rare, grave, and often fatal autoimmune disease causing the destruction and inflammation of small blood vessels that can impact several different organ systems, and often involves the kidneys.The crucial trial achieved both objectives of clinical remission at weeks 26 and 52 with statistical superiority of Avacopan over the standard of care at both time frames, and significantly higher at 52 weeks.5-star H.C. Wainwright analyst Edward White was taken aback by the results, noting, “The superiority finding was a positive surprise. As a reminder, the company is planning to market avacopan on its own in...
LONDON/FRANKFURT/MADRID (Reuters) - Bridgepoint has been sounding out possible bidders for its Portuguese agrochemical company Rovensa ahead of an auction process early next year that could raise about 800 million euros (£687.26 million), five sources told Reuters. The European private equity fund has hired HSBC to handle the so-called pre-marketing talks for the Lisbon-based crop protection company which was previously known as Sapec Agro, the sources said, speaking on condition of anonymity. Several private equity investors have already come forward for the business which also provides fertilizers such as micronutrients and biostimulants, the sources said....
Ripple has completed its commitment to buy $50 million worth of equity in money remittance service MoneyGram. In a press release shared with Coin Rivet, MoneyGram announced that Ripple had successfully acquired a further $20 million worth of equity in the NASDAQ-listed company having already invested $30 million earlier this year. Ripple purchased newly created equity at a price of $4.10 per share, which is significantly higher than MoneyGram’s current market price of around $3.00. However, the extra capital will be used to develop 'On-Demand Liquidity' (ODL) solutions. Ripple’s ODL technology uses XRP digital assets to send money globally and instantly for low fees. Chairman and CEO of MoneyGram Alex Holmes said of the investment: "Our partnership with Ripple isThe post Ripple completes investment in MoneyGram with additional $20 million appeared first on Coin Rivet....
In an interesting turn of events, cannabis stocks have been surging back from the dead. Among those rallying higher, Aurora Cannabis (NYSE:ACB) has enjoyed healthy gains lately. Despite rallying 18.2% on Nov. 21 and more than 45% from its low earlier that week, ACB stock still has a lot of overhead resistance.With the ACB stock price recently closing at $2.52, or down over 22% from the Nov. 21 high, you can appreciate how strong that resistance is.InvestorPlace - Stock Market News, Stock Advice & Trading TipsSetting that aside, if you were to give most stocks a 45% rally in three days -- even from its 52-week lows -- they would likely be in a pretty good technical position. The fact that ACB stock is not tells us how bad of a situation it's really in.It's incredible how fast this stock -- and many of its peers -- went from the high...
Third-quarter results from NVIDIA Corporation (NASDAQ: NVDA ) and Advanced Micro Devices, Inc. (NASDAQ: AMD ) suggest a gaming recovery is on track, according to Bank of America. The Analyst Vivek Arya ......
New data offers detail into Mike Bloomberg’s splashy entrance into the 2020 presidential contest....
